Toxicologic and antitumor studies on 5-hydroxymethyldeoxyuridine.
Toxicologic and antitumor studies on 5-hydroxymethyldeoxyuridine.
复制标题
5-羟甲基脱氧尿苷的毒理学和抗肿瘤研究。
DOI:
10.1016/0041-008x(85)90140-1
复制
发表时间:
1985
影响因子:
3.8
通讯作者:
A. Paterson
中科院分区:
文献类型:
--
作者:
J. B. Meldrum;V. S. Gupta;N. Lowes;A. Paterson
Toxic effects of 5-hydroxymethyldeoxyuridine (HMUdR) were studied in white Swiss mice. Pathological, hematological, and clinical chemistry parameters were examined. Systemic toxicity was not observed in mice after ip administration of HMUdR in single doses up to 2000 kg/kg. Mice administered HMUdR daily for 15 days at 200 mg/kg, ip, manifested loss of weight, rough hair coat, diarrhea, swollen abdomens, weakness, lethargy, and a 20% mortality rate. Hematological and clinical chemistry parameters of all mice receiving HMUdR were within normal limits. At necropsy, all organs were grossly normal but microscopic examination of tissues of treated mice revealed the presence of shortened, thickened villi in the small intestine, nuclear vacuolation and necrosis of intestinal crypt epithelial cells, and some cytoplasmic vacuolation causing nuclear margination in hepatocytes. All histological lesions were reversible with cessation of treatment. HMUdR was active against murine L1210 and L5178Y leukemias in cell culture. The concentrations required to inhibit cell growth 50% compared to untrated cells was 2 and 4 μm, respectively. When HMUdR was administered ip at 50, 100, or 200 mg/kg in five daily doses to mice implanted with L1210 cells, life spans increased 20, 30, or 33% over placebo-treated controls.